☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
option and license agreement
AbbVie Enters into an Exclusive Option and License Agreement for HPN217 and Expands its Existing Collaboration with Harpoon Therap...
November 21, 2019
Regenxbio Signs an Exclusive Worldwide Option and License Agreement with Clearside Biomedical to Evaluate its Delivery Platform fo...
September 4, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.